Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2017
Dec. 31, 2016
REVENUES    
Neurometric Services $ 53,300 $ 22,200
Telepsychiatry Services 68,700
Total Revenues 122,000 22,200
OPERATING EXPENSES    
Cost of revenue 84,900 3,700
Research 81,500 31,600
Product development 269,200 295,300
Sales and marketing 667,200 105,700
General and administrative 1,774,800 1,021,800
Total operating expenses 2,877,600 1,458,100
OPERATING LOSS (2,755,600) (1,435,900)
OTHER INCOME (EXPENSE):    
Interest expense, net (13,700) (2,500)
LOSS BEFORE PROVISION FOR INCOME TAXES (2,769,300) (1,438,400)
Income taxes 1,800
NET LOSS $ (2,769,300) $ (1,440,200)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share): $ (0.64) $ (0.69)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic and Diluted (in shares) 4,332,927 2,101,061